Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Caremark Dismisses “Rationale” Behind Express Scripts’ Bid

This article was originally published in The Pink Sheet Daily

Executive Summary

Pharmacy benefits manager says it will move forward with planned CVS merger.

You may also be interested in...

Express Scripts Emphasizes Offer Premium In Letter To Caremark Shareholders

Firm urges shareholders to “send a message to the Caremark board and management” regarding its acquisition bid.

Express Scripts/Caremark Combination Would Create “World’s Preeminent” PBM

Express Scripts’ $26 billion hostile bid for Caremark represents a 15 percent premium over CVS’ offer.

CVS' Merger With Caremark Gives Pharmacy "Access To Payers"

A year in the making, the transaction could reshape the retail pharmacy landscape.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts